• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests.

作者信息

Wu Yanyan, Ma Zhuang, Guo Xiaozhong, Li Hongyu, Tang Yufu, Meng Hao, Yu Hao, Peng Chengfei, Chu Guiyang, Wang Xinwei, Teng Yue, Zhang Quanyu, Zhu Tianyi, Wang Bing, Tong Zhenhua, Feng Ruirui, Zhao Haitao, Lu Hui, Qi Xingshun

机构信息

COVID-19 Study Group, General Hospital of Northern Theater Command, Shenyang, 110840, P.R. China; Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, 110840, P.R. China; Postgraduate College, Jinzhou Medical University, Jinzhou, 121000, P.R. China.

COVID-19 Study Group, General Hospital of Northern Theater Command, Shenyang, 110840, P.R. China; Department of Respiratory Medicine, General Hospital of Northern Theater Command, Shenyang, 110840, P.R. China; No. 7 Department of Infectious Diseases, Wuhan Huoshenshan Hospital, Wuhan, 430113, P.R. China.

出版信息

Ann Hepatol. 2021 Sep-Oct;24:100349. doi: 10.1016/j.aohep.2021.100349. Epub 2021 Apr 20.

DOI:
10.1016/j.aohep.2021.100349
PMID:33862291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8056851/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/8056851/2d41ae3fca14/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/8056851/2d41ae3fca14/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/8056851/2d41ae3fca14/gr1_lrg.jpg

相似文献

1
Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests.肝功能生化检查异常的新型冠状病毒肺炎患者的特征及院内结局
Ann Hepatol. 2021 Sep-Oct;24:100349. doi: 10.1016/j.aohep.2021.100349. Epub 2021 Apr 20.
2
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.前瞻性拉丁美洲队列研究评估 COVID-19 患者入院时肝功能异常的结局。
Ann Hepatol. 2021 Mar-Apr;21:100298. doi: 10.1016/j.aohep.2020.100298. Epub 2021 Jan 7.
3
Prevalence of Abnormal Liver Function Tests in COVID-19 Patients at a Tertiary Care Centre.三级医疗中心新冠肺炎患者肝功能检查异常的患病率
J Assoc Physicians India. 2020 Aug;68(8):73-75.
4
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
5
Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.2019 冠状病毒病患者肝功能参数的动态变化：一项多中心、回顾性研究。
BMC Infect Dis. 2021 Aug 16;21(1):818. doi: 10.1186/s12879-021-06572-z.
6
Clinical characteristics of COVID-19 patients with abnormal liver tests.肝功能检查异常的新冠病毒肺炎患者的临床特征
J Hepatol. 2020 Sep;73(3):712-713. doi: 10.1016/j.jhep.2020.04.028. Epub 2020 Apr 26.
7
Reply to: 'Abnormal liver function tests and coronavirus disease 2019: A close relationship'.回复：“肝功能检查异常与2019冠状病毒病：密切关系”
J Viral Hepat. 2023 Jan;30(1):81. doi: 10.1111/jvh.13773. Epub 2022 Nov 21.
8
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.新型冠状病毒肺炎患者肝损伤的发生率及其与临床结局的相关性：系统评价与荟萃分析。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13072-13088. doi: 10.26355/eurrev_202012_24215.
9
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease.基线肝功能检查在无慢性肝病的 COVID-19 患者结局中的表现、模式和预测价值。
World J Gastroenterol. 2021 Nov 14;27(42):7350-7361. doi: 10.3748/wjg.v27.i42.7350.
10
Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.动态肝功能变化及其与 COVID-19 患者疾病严重程度和死亡率的相关性：一项回顾性队列研究。
Clin Interv Aging. 2021 Apr 21;16:675-685. doi: 10.2147/CIA.S303629. eCollection 2021.

引用本文的文献

1
Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study.糖尿病可能会加重COVID-19患者的肝损伤：一项单中心、观察性、回顾性研究。
Diabetes Ther. 2022 Dec;13(11-12):1847-1860. doi: 10.1007/s13300-022-01318-9. Epub 2022 Sep 22.
2
Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study.质子泵抑制剂对新型冠状病毒肺炎患者院内结局的影响：一项回顾性研究
Therap Adv Gastroenterol. 2022 Jun 14;15:17562848221104365. doi: 10.1177/17562848221104365. eCollection 2022.
3
Gastrointestinal Bleeding, but Not Other Gastrointestinal Symptoms, Is Associated With Worse Outcomes in COVID-19 Patients.

本文引用的文献

1
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.前瞻性拉丁美洲队列研究评估 COVID-19 患者入院时肝功能异常的结局。
Ann Hepatol. 2021 Mar-Apr;21:100298. doi: 10.1016/j.aohep.2020.100298. Epub 2021 Jan 7.
2
Prognostic value of liver biochemical parameters for COVID-19 mortality.肝脏生化参数对 COVID-19 死亡率的预后价值。
Ann Hepatol. 2021 Mar-Apr;21:100279. doi: 10.1016/j.aohep.2020.10.007. Epub 2020 Nov 4.
3
COVID 19 and liver: An A-Z literature review.COVID-19 与肝脏：文献综述 A-Z。
胃肠道出血而非其他胃肠道症状与COVID-19患者更差的预后相关。
Front Med (Lausanne). 2021 Oct 13;8:759152. doi: 10.3389/fmed.2021.759152. eCollection 2021.
4
Elevations in Liver Transaminases in COVID-19: (How) Are They Related?新型冠状病毒肺炎中肝转氨酶升高：它们（如何）相关？
Front Med (Lausanne). 2021 Jul 15;8:705247. doi: 10.3389/fmed.2021.705247. eCollection 2021.
5
Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.新型冠状病毒肺炎患者反复病毒聚合酶链反应阳性的临床特征及相应免疫功能状态：荟萃分析和系统评价。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211027679. doi: 10.1177/20587384211027679.
Dig Liver Dis. 2021 Feb;53(2):146-152. doi: 10.1016/j.dld.2020.09.010. Epub 2020 Sep 16.
4
The effect of liver test abnormalities on the prognosis of COVID-19.肝脏试验异常对 COVID-19 预后的影响。
Ann Hepatol. 2020 Nov-Dec;19(6):614-621. doi: 10.1016/j.aohep.2020.08.068. Epub 2020 Sep 10.
5
Systemic inflammation as fuel for acute liver injury in COVID-19.系统性炎症为 COVID-19 急性肝损伤提供燃料。
Dig Liver Dis. 2021 Feb;53(2):158-165. doi: 10.1016/j.dld.2020.08.004. Epub 2020 Aug 10.
6
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.新型冠状病毒肺炎患者肝功能异常的发生率、危险因素及预后的系统评价和荟萃分析。
Hepatol Int. 2020 Sep;14(5):621-637. doi: 10.1007/s12072-020-10074-6. Epub 2020 Jul 24.
7
Involvement of liver in COVID-19: systematic review and meta-analysis.新型冠状病毒肺炎中肝脏受累情况：系统评价与荟萃分析
Gut. 2021 Apr;70(4):807-809. doi: 10.1136/gutjnl-2020-322072. Epub 2020 Jul 15.
8
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.肝脏受累与死亡率无关：来自大型 SARS-CoV-2 阳性患者队列的结果。
Aliment Pharmacol Ther. 2020 Sep;52(6):1060-1068. doi: 10.1111/apt.15996. Epub 2020 Aug 1.
9
Liver tests abnormalities in COVID-19: trick or treat?新冠病毒感染中的肝脏检查异常：是陷阱还是机遇？
J Hepatol. 2020 Nov;73(5):1275-1276. doi: 10.1016/j.jhep.2020.05.033. Epub 2020 May 27.
10
The liver in times of COVID-19: What hepatologists should know.COVID-19 时期的肝脏：肝病学家应该了解的知识。
Ann Hepatol. 2020 Jul-Aug;19(4):353-358. doi: 10.1016/j.aohep.2020.05.001. Epub 2020 May 18.